Mongolian hospital introduces Revo-i robotic surgical system

Mongolia’s First Central Hospital has introduced the Revo-i robotic surgical system, developed by South Korean medical technology company Meerecompany, as the hospital expands its use of robotic-assisted surgery.

According to Mongolian news agency Montsame, the system is expected to support surgeons in performing complex procedures, including operations involving lesions and conditions in hard-to-reach areas. First Central Hospital Director General Ankhtuya P. said the hospital plans to expand the use of the technology and improve public access to robotic surgery.

Ankhtuya also said the hospital intends to incorporate the service into Mongolia’s health insurance system, although the reports do not indicate that such coverage has already been implemented.

The installation at First Central Hospital follows Meerecompany’s earlier deployment of the Revo-i at Mongolia’s National Cancer Center. In an announcement published in July, Meerecompany described the First Central Hospital installation as its second Revo-i export to Mongolia.

First Central Hospital is a 568-bed tertiary hospital and is involved in complex medical procedures, including organ transplantation. Meerecompany said the new robotic system could support the hospital’s development of robotic surgery in areas including transplantation.

The Revo-i is a robotic-assisted surgical platform developed by Meerecompany, a South Korean medical technology company. The system is designed to allow surgeons to perform minimally invasive procedures using robotic instruments controlled from a surgical console.

The company has been expanding the Revo-i’s presence outside South Korea, with installations reported in several international markets.

The introduction at First Central Hospital represents the second reported deployment of the Revo-i in Mongolia and adds robotic-assisted surgery capacity at one of the country’s major tertiary healthcare institutions.